Zomedica Reports Reduced Net Loss for Third Quarter 2026
Zomedica Corp. (ZOMDF) has released its financial results for the third quarter ending September 30, 2026. The company reported a net loss of $3.2 million for the period, representing a significant improvement compared to the $6.1 million net loss recorded during the same three-month period in 2025. In addition to the financial results, the company is focusing on its clinical programs and evidence-driven adoption strategies within the veterinary products market. Management continues to emphasize demand creation as a primary driver for revenue growth across its distinct product portfolios.
